These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The amino acid region 248-382 of the Epstein-Barr virus nuclear protein 2 (EBNA2) is responsible for the EBNA2-induced EBV reactivation. Fujiwara S; Liu E; Shimizu K Virus Genes; 2001 Dec; 23(3):361-5. PubMed ID: 11778704 [TBL] [Abstract][Full Text] [Related]
23. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Peng M; Lundgren E Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347 [TBL] [Abstract][Full Text] [Related]
24. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells. Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972 [TBL] [Abstract][Full Text] [Related]
25. Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines. Zhang RD; Guan M; Park Y; Tawadros R; Yang JY; Gold B; Wu B; Henderson EE AIDS Res Hum Retroviruses; 1997 Jan; 13(2):161-71. PubMed ID: 9007201 [TBL] [Abstract][Full Text] [Related]
26. Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally. Lin CS; Kuo HH; Chen JY; Yang CS; Wang WB J Mol Biol; 2000 Oct; 303(1):7-23. PubMed ID: 11021966 [TBL] [Abstract][Full Text] [Related]
27. EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cells. Boccellato F; Anastasiadou E; Rosato P; Kempkes B; Frati L; Faggioni A; Trivedi P J Virol; 2007 Mar; 81(5):2274-82. PubMed ID: 17151114 [TBL] [Abstract][Full Text] [Related]
28. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance. Gordadze AV; Onunwor CW; Peng R; Poston D; Kremmer E; Ling PD J Virol; 2004 Apr; 78(8):3919-29. PubMed ID: 15047808 [TBL] [Abstract][Full Text] [Related]
29. The CR4 region of EBNA2 confers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling. Grabusic K; Maier S; Hartmann A; Mantik A; Hammerschmidt W; Kempkes B J Gen Virol; 2006 Nov; 87(Pt 11):3169-3176. PubMed ID: 17030849 [TBL] [Abstract][Full Text] [Related]
30. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2. Hsieh JJ; Hayward SD Science; 1995 Apr; 268(5210):560-3. PubMed ID: 7725102 [TBL] [Abstract][Full Text] [Related]
31. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. Ning S; Hahn AM; Huye LE; Pagano JS J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551 [TBL] [Abstract][Full Text] [Related]
32. A role for SKIP in EBNA2 activation of CBF1-repressed promoters. Zhou S; Fujimuro M; Hsieh JJ; Chen L; Hayward SD J Virol; 2000 Feb; 74(4):1939-47. PubMed ID: 10644367 [TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context. Cordier-Bussat M; Billaud M; Calender A; Lenoir GM Int J Cancer; 1993 Jan; 53(1):153-60. PubMed ID: 8416201 [TBL] [Abstract][Full Text] [Related]
34. EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes. Zimber-Strobl U; Strobl LJ Semin Cancer Biol; 2001 Dec; 11(6):423-34. PubMed ID: 11669604 [TBL] [Abstract][Full Text] [Related]
35. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421 [TBL] [Abstract][Full Text] [Related]
36. Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa. Bourillot PY; Waltzer L; Sergeant A; Manet E J Gen Virol; 1998 Feb; 79 ( Pt 2)():363-70. PubMed ID: 9472621 [TBL] [Abstract][Full Text] [Related]
37. Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. Höfelmayr H; Strobl LJ; Marschall G; Bornkamm GW; Zimber-Strobl U J Virol; 2001 Mar; 75(5):2033-40. PubMed ID: 11160707 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation. Fuentes-Pananá EM; Ling PD J Virol; 1998 Jan; 72(1):693-700. PubMed ID: 9420275 [TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416 [TBL] [Abstract][Full Text] [Related]
40. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Floettmann JE; Ward K; Rickinson AB; Rowe M Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]